Immix Biopharma (IMMX) closed at $8.35 on November 10, 2026, down 2.6% from the previous close, on volume of 759,936 shares (30-day average 1,449,843).
Data as of November 10, 2026.
10-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 9, 2026. See the 10 largest for 30, 60 and 90 days
Globe Newswire (Wed, 4-Nov 9:15 AM ET)
Immix Biopharma to Participate in the 45th Annual J.P. Morgan Healthcare Conference
Globe Newswire (Mon, 5-Oct 8:45 AM ET)
Immix Biopharma Announces Closing of $125 Million Underwritten Offering of Common Stock
Globe Newswire (Wed, 30-Sep 5:15 PM ET)
Market Chameleon (Tue, 29-Sep 3:30 AM ET)
Immix Biopharma Announces Pricing of $125 Million Underwritten Offering of Common Stock
Globe Newswire (Tue, 29-Sep 7:05 AM ET)
Globe Newswire (Tue, 29-Sep 7:00 AM ET)
Globe Newswire (Tue, 11-Aug 6:23 PM ET)
Market Chameleon (Wed, 28-Jan 4:04 AM ET)
Immix Biopharma Secures $100 Million in Upsized Offering Backed by Leading Biotechnology Investors
Market Chameleon (Wed, 10-Dec 3:20 AM ET)
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
Immix Biopharma trades on the NASDAQ stock market under the symbol IMMX.
As of November 10, 2026, IMMX stock price declined to $8.35 with 759,936 million shares trading.
IMMX has a beta of 1.04, meaning it tends to be more sensitive to market movements. IMMX has a correlation of 0.02 to the broad based SPY ETF.
IMMX has a market cap of $692.24 million. This is considered a Small Cap stock.
In the last 3 years, IMMX traded as high as $15.10 and as low as $1.26.
The top ETF exchange traded funds that IMMX belongs to (by Net Assets): VTI, XBI, IWM, VXF, IWO.
IMMX has outperformed the market in the last year with a price return of +165.1% while the SPY ETF gained +12.9%. However, in the short term, IMMX had mixed performance relative to the market. It has underperformed in the last 3 months, returning -14.1% vs -2.8% return in SPY. But in the last 2 weeks, IMMX shares have fared better than the market returning +3.6% compared to SPY -2.0%.
IMMX support price is $8.10 and resistance is $9.04 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IMMX shares will trade within this expected range on the day.
